Start with the user’s problem — what’s the question you’re trying to answer?
You’re trying to get clear, usable data that tells you whether a candidate is worth taking further; nothing daft, just reliable answers fast. If your lead programme leans on gut biology, you might start by engaging a specialist like gastroenterology CRO early so assays, animal models and endpoints line up with your go/no‑go gates. Say what you need: target engagement, PK/PD, safety margins, reproducibility. Say it plain. That focus directs every choice after.
Define decisions and timelines that matter to you
List the decisions your team must make at each milestone and the data that will change them. Short timelines mean prioritise assays with rapid turnarounds; longer programmes can absorb more complex disease models. Keep acceptance criteria simple: what numerical change, what effect size, what variability will trigger the next step. Match study length to decision urgency. No waffle — just a map from question to data to decision.
Choose partners by scientific fit, not just price
Match expertise to need. A partner who knows your target biology will save time on assay transfer and interpretation. Look for examples of similar studies, clear methods for assay validation, and open data-sharing. Ask about sample handling, data formats, and their change control: can they adapt if a protocol tweak becomes necessary? Pay for capability; pennies saved on the wrong lab cost you months later.
Common mistakes teams make and how to avoid them
Expect three traps. One: vague endpoints that let results be argued away. Two: late alignment on statistics and acceptance criteria. Three: hidden operational issues — shipping, blinding, batch effects. Fix these by documenting endpoints and stats beforehand, running a pilot when uncertain, and agreeing SOPs for sample handling. Keep lines short: daily or twice‑weekly check‑ins during critical runs. That’s where most programmes fall over, not the science itself.
Experience, expertise and a real-world anchor
Work with labs that can point to tangible experience rather than platitudes. Teams who present methods and data at recognised meetings such as Digestive Disease Week demonstrate peer scrutiny and reproducibility. Practical expertise includes validated rodent models for GI inflammation, clear PK/PD linkage, and GLP-capable safety pipelines. If you want a focused partner for GI programmes, evaluate a gastrointestinal CRO by asking for published protocols, blinded study examples, and the names of external collaborators who can corroborate capability.
Short, practical checklist before you sign
Does the CRO understand your decision gates? Have you agreed primary and secondary endpoints and the statistical plan? Can they demonstrate prior work on your disease area? Is data export in a usable format for your analysts? Who owns samples and raw data? Have you budgeted for repeats? If any answer is fuzzy, sort it before work begins.
Where this all leads
Make partner selection a user‑centred process: define decisions first, then pick the lab that maps to those decisions with transparent methods and proven GI experience. That approach keeps your programme lean and your choices defensible, the sort of practical match you find when teams partner with KCI Biotech for focused preclinical support.
